A clinical trial of adjunctive oestrogen treatment in women with schizophrenia

Archives of Women's Mental Health

Volumn 5, Issue 3, 2002, Pages 99-104

  Kulkarni, Jayashiri ^a,d   Riedel, A ^a   De Castella, A R ^a   Fitzgerald, P B ^a   Rolfe, T J ^a   Taffe, J ^b   Burger, H ^c  

^a MONASH UNIVERSITY   (Australia)

^b SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

^c MONASH MEDICAL CENTRE   (Australia)

^d ALFRED HOSPITAL   (Australia)

Author keywords

Dopamine; Oestrogen estrogen; Prolactin; Schizophrenia; Serotonin

Indexed keywords

DOPAMINE; ESTRADIOL; ESTROGEN; ETHINYLESTRADIOL; PLACEBO; PROLACTIN; SEROTONIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE CALCULATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ESTROGEN BLOOD LEVEL; ESTROGEN THERAPY; FEMALE; HORMONAL REGULATION; HUMAN; LIVER MICROSOME; MENSTRUAL CYCLE; NEUROPROTECTION; PRIORITY JOURNAL; RATING SCALE; RECEPTOR DENSITY; SCHIZOPHRENIA;

ADMINISTRATION, CUTANEOUS; ADULT; ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ESTRADIOL; FEMALE; HUMANS; PILOT PROJECTS; SCHIZOPHRENIA;

EID: 0036854211     PISSN: 14341816     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00737-002-0001-5     Document Type: Article

References (17)

1. Di Paolo T (1994) Modulation of brain dopamine transmission by sex steroids. Rev Neurosci 5: 27-41.
2. Di Paolo T, Poyet P, Labrie F (1981) Effect of chronic estradiol and haloperidol treatment on striatal dopamine receptors. Eur J Pharmacol 73: 105-106.
3. Di Paolo T, Poyet P, Labrie F (1982) Effect of prolactin and estradiol on rat striatal dopamine receptors. Life Sci 31: 2921-2929.
4. Grunder G, Wetzel H, Schlosser R, Anghelescu I, Hillert A, Lange K, Hiemke C, Benkert O (1999) Neuroendocrine response to antipsychotics: Effects of drug type and gender. Biol Psychiatry 45: 89-97.
5. Häfner H, Behrens S, De Vry J, Gattaz WF (1991) An animal model for the effects of estradiol on dopamine-mediated behavior: Implications for sex differences in schizophrenia. Psychiatry Res 38: 125-134.
6. Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13: 261-276.
7. Kulkarni J, deCastella A, Thompson K (1994) Assessment of menstrual cycle phase in women. Biennial Winter Workshop on Schizophrenia.
8. Kulkarni J, de Castella A, Smith D, Taffe J, Keks N, Copolov D (1996) A clinical trial of the effects of estrogen in acutely psychotic women. Schizophr Res 20: 247-252.
9. Kulkarni J, deCastella A, Taffe J (1999) Clinical adjunctive estrogen trial in men with schizophrenia: A pilot study. Schizophr Res 36: 286 (abstract).
10. Kulkarni J, Reidel A, de Castella A, Fitzgerald P, Rolfe T, Taffe J, Burger H (2001) Estrogen - A potential treatment for schizophrenia. Schizophr Res 48: 137-144.
11. McDermott JL, Liu B, Dluzen DE (1994) Sex differences and effects of estrogen on dopamine and DOPAC release from the striatum of male and female CD-1 mice. Exp Neurol 125: 306-311.
12. Riecher-Rössler A, Häfner H, Dutsch-Strobel A, Oster M, Stumbaum M, van Gulick-Bailer M, Löffler W (1994) Further evidence for a specific role of estradiol in schizophrenia? Biol Psychiatry 36: 492-494.
13. Seeman MV (1986) Current outcome in schizophrenia: Women vs. men. Acta Psychiatr Scand 73: 609-617.
14. Seeman MV (1996) The role of estrogen in schizophrenia. J Psychiatry Neurosci 21: 123-127.
15. Seeman MV, Lang M (1990) The role of estrogens in schizophrenia gender differences. Schizophr Bull 16: 185-194.
16. Sumner BE, Fink G (1998) Testosterone as well as estrogen increases serotonin 2A receptor mRNA and binding site densities in the male rat brain. Brain Res Mol Brain Res 59: 205-214.
17. Yonkers KA, Kando JC, Cole JO, Blumenthal S (1992) Gender differences in pharmacokinetics and pharmacodynamics of psychotropic medication. Am J Psychiatry 149: 587-595.